Market Overview

Credit Suisse Maintains on Covisint

Related COVS
Mid-Afternoon Market Update: Crude Oil Up 1%; HD Supply Holdings Shares Plummet
18 Biggest Mid-Day Gainers For Tuesday

In a report published Friday, Credit Suisse analyst Michael Nemeroff maintained Outperform on Covisint (NASDAQ: COVS), dropping its target price to $17.00 from $18.00.

According to the report, the analyst's $17.00 target price is based on a blended average using 50 percent of their discounted cash flow (DCF) valuation and 50% of their relative comparable multiples to its peers.

“We believe that this target price and multiple are warranted due to our confidence that the company's previously signed ASR gives a high degree of visibility into future revenue growth, that it will continue to diversify its revenue base by successfully expanding its platform into new verticals, and that demand for PaaS in mature markets will increase over the next few years,” the report noted.

COVS closed Thursday at $12.84.

Latest Ratings for COVS

Sep 2015Credit SuisseAssumesUnderperform
Mar 2015Credit SuisseDowngradesNeutralUnderperform
May 2014Pacific CrestDowngradesOutperformSector Perform

View More Analyst Ratings for COVS
View the Latest Analyst Ratings

Posted-In: Credit Suisse Michael NemeroffAnalyst Color Reiteration Analyst Ratings


Related Articles (COVS)

View Comments and Join the Discussion!